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Evidence for an Interferon-Inducible Gene, Ifi202,
in the Susceptibility to Systemic Lupus
human SLE. Considerable evidence indicates that the
development of lupus in humans and in this murine
model has a strong but complex genetic basis (Harley
Stephen J. Rozzo,1 John D. Allard,2 Divaker Choubey,3
Timothy J. Vyse,1,7 Shozo Izui,4 Gary Peltz,2
and Brian L. Kotzin1,5,6
et al., 1998; Vyse and Kotzin, 1998; Theofilopoulos and1Departments of Medicine and Immunology
Kono, 1999; Wakeland et al., 1999). In different geneticUniversity of Colorado Health Sciences Center
analyses of crosses involving the NZB and NZW strains,Denver, Colorado 80262
major histocompatibility complex (MHC) and multiple2 Roche Bioscience
non-MHC loci from both New Zealand strains have beenPalo Alto, California 94304
shown to contribute to disease (Vyse and Kotzin, 1998;3 Department of Radiation Oncology
Wakeland et al., 1999; Theofilopoulos and Kono, 1999).Stritch School of Medicine
However, none of the susceptibility genes underlyingLoyola University Medical Center
these contributions has yet been identified.Maywood, Illinois 60153
When different mapping studies are compared, some4 Department of Pathology
chromosomal regions have shown consistent linkageCentre Me´dical Universitaire
with lupus traits in New Zealand mice. Perhaps most1211 Geneva 4
striking are loci on distal chromosome 1, for which con-Switzerland
tributing genes from both the NZB and NZW have been5 Department of Medicine
localized (Morel et al., 1994; Kono et al., 1994; Drake etNational Jewish Medical and Research Center
al., 1995; Rozzo et al., 1996, 2000; Vyse and Kotzin,Denver, Colorado 80206
1998; Vyse et al., 1997, 1998; Wakeland et al., 1999). In
our laboratory, a NZB lupus-susceptibility locus on distal
chromosome 1 (named Nba2 for New Zealand blackSummary
autoimmunity 2) has been apparent in multiple different
backcrosses (Drake et al., 1995; Kotzin, 1996; Rozzo etThe Nba2 locus is a major genetic contribution to dis-
al., 1996, 2000; Vyse et al., 1997, 1998). In one cross,ease susceptibility in the (NZBNZW)F1 mouse model
we found that Nba2, in combination with the NZW MHCof systemic lupus. We generated C57BL/6 mice con-
haplotype, accounted for90% of the genetic contribu-genic for this NZB locus, and these mice produced
tion to IgG autoantibody production and disease (Rozzoantinuclear autoantibodies characteristic of lupus. F1 et al., 1996). In different crosses, Nba2 also showedoffspring of congenic and NZW mice developed high
evidence for linkage as a quantitative trait locus withautoantibody levels and severe lupus nephritis similar
nearly all of the lupus autoantibodies studied, including
to (NZB  NZW)F1 mice. Expression profiling with oligo- IgG autoantibodies to chromatin, DNA, histones, and
nucleotide microarrays revealed only two differentially
the retroviral envelope glycoprotein, gp70 (Vyse et al.,
expressed genes, interferon-inducible genes Ifi202 and 1997, 1998). On the basis of these findings and enhanc-
Ifi203, in congenic versus control mice, and both were ing effects on total IgG levels, we hypothesized that
within the Nba2 interval. Quantitative PCR localized Nba2 may act as an immune response gene that influ-
increased Ifi202 expression to splenic B cells and non- ences antigen-driven B cell responses to self and possi-
T/non-B cells. These results, together with analyses bly to exogenous antigens.
of promoter region polymorphisms, strain distribution The genes that predispose to lupus are likely to be
of expression, and effects on cell proliferation and related to key immunologic checkpoints in the disease
apoptosis, implicate Ifi202 as a candidate gene for process, and the identification of these genes will almost
lupus. certainly provide important insight into the cause of this
autoimmune disease and potential new targets for ther-
Introduction apy. In the present study, we generated mice congenic
for the Nba2 locus and show the contribution of this
Systemic lupus erythematosus (SLE) is considered to chromosomal region to autoantibody production and
be the prototypic systemic autoimmune disease. The lupus nephritis. Expression profiling with oligonucleo-
common denominator among SLE patients is IgG auto- tide microarrays demonstrated differential expression
antibody production, and the hallmark of this disease is of two interferon-inducible genes, and both localized to
elevated serum levels of antinuclear antibodies (Kotzin, the Nba2 interval. These results, with additional studies
of the Ifi202 gene and Nba2-caused traits, provide evi-1996). Hybrids of New Zealand black (NZB) and New
dence for a new candidate gene in the development ofZealand white (NZW) mice develop a severe immune
lupus autoimmunity.complex-mediated glomerulonephritis associated with
high serum levels of IgG antinuclear autoantibodies, and
Resultsthese mice are considered to be an excellent model of
Generation of B6.Nba2 Congenic Mice6 Correspondence: brian.kotzin@uchsc.edu
and Characterization of Lupus Traits7 Present address: Rheumatology Section, Imperial College School
To characterize the Nba2 lupus-susceptibility locus, weof Medicine, Hammersmith Campus, London W12 ONN, United
Kingdom. repeatedly backcrossed this NZB chromosomal region
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Figure 1. Map of the Distal End of Chromo-
some 1 Encompassing Nba2
The Nba2 interval that has been implicated
in linkage analyses (Drake et al., 1995; Rozzo
et al., 1996, 2000; Vyse et al., 1997, 1998; Vyse
and Kotzin, 1998) and the NZB chromosomal
region present in the B6.Nba2 congenic strain
(NZB, thick line; B6, thin line) are shown in
the figure. The left side of the figure shows
microsatellite markers and gene polymor-
phisms used to characterize introgressed
NZB regions. On the right side, selected can-
didate genes in the Nba2 interval are shown:
Fcgr2b and Fcgr3, Fc receptor for IgG, low
affinity, type 2b and type 3; Ctl1, cytotoxic
lymphocyte response 1; Fcer1g and Fcer1a,
Fc receptor for IgE, high affinity, type 1 
and  chain; Nmrk, non-MHC restricted killing
associated; Slam, signaling lymphocyte acti-
vation molecule; Crp, C-reactive protein; Sap,
serum amyloid P component; Ifi202–204, in-
terferon-activated genes 202–204; Adprt (or
Parp), poly ADP ribose polymerase.
on distal chromosome 1 to the nonautoimmune C57BL/6 NZW)F1 mice served as positive and negative controls,
respectively, for these F1 studies. A high frequency (95%)(B6) strain and then intercrossed siblings to generate
B6.NZB-Nba2 (designated B6.Nba2) congenic mice ho- of (B6.Nba2  NZW)F1 progeny developed elevated au-
toantibody levels and severe proteinuria and died frommozygous for the interval. Other chromosomal regions
known to contain susceptibility loci (Vyse and Kotzin, lupus nephritis (Figures 2 and 3). The time course of
disease was similar to (NZBNZW)F1 mice in our colony1998; Wakeland et al., 1999; Theofilopoulos and Kono,
1999) were verified to be negative for NZB alleles, and (Drake et al., 1995). In contrast, almost none (5%) of the
(B6  NZW)F1 controls developed detectable autoanti-mice were homozygous for H2b of the B6 strain. The
NZB chromosome 1 interval in the congenic mice ex-
tended from 79–109 cM, which encompassed the
Nba2 interval (90–98 cM) implicated in linkage studies
(Figure 1) (Vyse and Kotzin, 1998; Rozzo et al., 1996,
2000; Vyse et al., 1997, 1998).
Female congenic B6.Nba2 mice were followed for the
development of lupus nephritis, and sera were serially
sampled for elevated levels of IgG autoantibodies char-
acteristic of lupus. Lupus nephritis, measured by high
levels of proteinuria, developed in only 3 of 29 B6.Nba2
mice (Figure 2). Congenic mice, however, developed
significantly elevated serum levels of IgG antinuclear
antibodies compared with B6 mice, including autoanti-
bodies to chromatin (p  0.05), double-stranded (ds)
DNA (p  0.01), and total histones (p  0.001) (Figure
3). Autoantibodies to endogenous retroviral gp70, in the
Figure 2. Development of Glomerulonephritis in Congenic and Con-form of gp70-anti-gp70 immune complexes, are another
trol Strainspathogenic autoantibody in (NZB  NZW)F1 mice (Vyse
Data are shown as the percentage of (B6.Nba2  NZW)F1 (, n et al., 1999), but these autoantibodies were not signifi-
22), (B6  NZW)F1 (, n  41), and B6.Nba2 (, n  29) micecantly different in B6.Nba2 versus B6 mice.
that developed severe proteinuria during the follow-up period. The
Congenic mice were crossed with NZW mice, and difference in frequency of disease in the (B6.Nba2  NZW)F1 mice
female (B6.Nba2NZW)F1 mice were followed for auto- compared with the other groups was highly significant by 8 months
of age (p  5  106).antibodies and nephritis. (NZB  NZW)F1 and (B6 
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Figure 3. Autoantibody Levels in Congenic
and Control Strains
Serum samples from 7-month-old B6,
B6.Nba2, (B6 NZW)F1, (B6.Nba2 NZW)F1,
and (NZB  NZW)F1 mice were analyzed for
IgG autoantibodies to chromatin (A), dsDNA
(B), total histones (C), and gp70-anti-gp70 im-
mune complexes (D). Comparisons between
B6.Nba2 and B6 mice were significantly dif-
ferent for IgG autoantibodies to chromatin
(p  0.05), dsDNA (p  0.01), and histones
(p  0.001). Levels of these autoantibodies
were also significantly different in (B6.Nba2 
NZW)F1 compared with (B6  NZW)F1 mice
(p  0.001) but were not statistically different
in (NZBNZW)F1 versus (B6.Nba2NZW)F1
mice (p  0.1). For gp70 immune complexes,
only levels in (NZB  NZW)F1 mice were sta-
tistically different compared with other
groups (p  0.001). Autoantibody levels were
compared using the nonparametric Dunn
procedure of the Kruskal-Wallis test.
body levels or showed evidence of renal disease. These cells from (NZB  NZW)F1 mice demonstrated interme-
diate levels of both Ifi202 and Ifi203. Analyses of NZBresults confirm the contribution of Nba2 to IgG autoanti-
body production and the importance of this locus in the cells also showed 146 separate differentially expressed
genes compared with B6. None of these other genesdevelopment of lupus nephritis, especially when other
NZW-derived susceptibility genes are present, as in localized to the Nba2 interval.
(NZBNZW)F1 mice (Drake et al., 1995; Vyse and Kotzin,
1998). Quantitation of Ifi202 Gene and Protein Expression
We used quantitative (real-time) PCR to confirm differ-
ences in Ifi202 mRNA expression among the differentScreening for Candidate Genes with Microarrays
strains. In studies of separate splenic samples, NZB andTo identify gene candidates within the Nba2 region, gene
B6.Nba2 mice expressed 10- to 100-fold more Ifi202expression in spleen cells from 4-month-old (preauto-
compared with matched samples from B6 and NZWimmune) B6.Nba2 and B6 mice was profiled using oligo-
mice (Figure 5A; see also Figure 7A). (NZB  NZW)F1nucleotide microarrays. Four mice from each group were
mice had an intermediate level of Ifi202 gene expression,initially studied, and criteria for differential expression
which was still 5- to 10-fold greater than NZW or B6required increases (or decreases) in 12 of the 16 possible
levels (Figure 5A). Spleens from the youngest NZB micepairwise comparisons (as analyzed by GeneChip 3.1
examined (6 weeks of age), well before features of auto-software; Affymetrix, Santa Clara, CA). Of the 11,000
genes analyzed, only two genes exhibited differences
in expression, and both localized to the Nba2 region
(Figure 4). The differences in average expression in two
interferon-inducible genes in the Ifi200 cluster (Ifi202
and Ifi203) were greater than 10-fold. B6.Nba2 spleen
cells expressed high levels of Ifi202 and low levels of
Ifi203, whereas the pattern was opposite in B6 cells. No
difference in expression of Ifi204 was apparent (shown
for comparison in Figure 4). No other probe set on the
chip, which included all of the candidate genes except
Slam shown on the right side of Figure 1, was differen-
tially expressed in B6.Nba2 versus B6 spleen cells. We
also analyzed kidney for differences in expression in a
similar manner, but the results showed no differences
localizing to the distal chromosome 1 interval. Ifi202
Figure 4. Microarray Analysis of Ifi200 Genes in Spleen Cells fromexpression was not detected in kidney from either strain.
B6.Nba2 and B6 Mice
Additional expression microarray analyses showed
Expression units (Average Difference Value as analyzed by Affyme-that NZB spleen cells expressed high levels (similar to
trix GeneChip 3.01 software) are shown for individual B6.Nba2 ()
B6.Nba2) and that NZW expressed low levels (similar to versus B6 () mice for probe sets from the full-length cDNAs of
B6) of Ifi202 (see below). Expression levels of Ifi203 were each gene. Ifi204 expression was not differentially expressed but
is shown for comparison.again reciprocally low in NZB and high in NZW. Spleen
Immunity
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form and a variant form of p202 that migrates slower
than the p202 in B6.Nba2 cells (Figure 5B) and various
cell lines (Choubey and Lengyel, 1993).
Ifi202 Promoter Region Polymorphisms in Different
Strains and Correlation with Contribution of Nba2
The genomic structure and sequence of Ifi202 have been
determined (Choubey et al., 1989; Wang et al., 1999),
and studies have shown that an 800 bp 5-flanking se-
quence of Ifi202 mediates promoter function (Gribaudo
et al., 1987; Samanta et al., 1986). Sequencing this region
disclosed eight different polymorphisms between NZB
and B6 strains, including a 3 bp (TTT) insertion proximal
to the interferon-stimulated response element (ISRE)-
like sequence in NZB (Figure 6).
A single nucleotide polymorphism (SNP) genotyping
assay was developed for the single nucleotide differ-
ence (C to T) at position 95, which was used as a marker
for the sequence differences between NZB and B6 pro-
moters. The allelic distribution among different mouse
strains (Figure 6) suggested that this polymorphism cor-
related with Ifi202 expression. The B6, B10, and NZW
strains have the T allele, and all exhibit low Ifi202 expres-
sion (Figure 5A). In contrast, BALB/c and NZB mice have
the C allele. NZB mice have high expression (Figure
5A), and others have shown that interferon inducers
Figure 5. Quantitation of Ifi202 Gene and Protein Expression among stimulate increased Ifi202 expression in BALB/c com-
Different Strains pared with B6 mice (Gribaudo et al., 1999). We also used
(A) Quantitative (real-time) PCR analysis of Ifi202 expression in whole allele-specific primers for a coding region nucleotide
spleen cell samples from different parental strains and (NZB 
difference between NZB and NZW and quantitative PCRNZW)F1 mice relative to the B6 expression level. Three separate
to determine which allele is expressed in the (NZB experiments showed that expression of Ifi202 in B6.Nba2 spleen
NZW)F1 strain. Using equal mixtures of genomic DNAvaried from 10- to 100-fold greater than B6.
(B) Immunoblotting of spleen cell lysates from different parental from the two stains and the absence of any template as
strains for p202 expression using an anti-p202 polyclonal antiserum. positive and negative controls, respectively, the results
The expression of the heat shock protein p68, which is also detected indicate that essentially only the NZB allele is expressed
with the anti-p202 antiserum, provides a control for the amount of
(data not shown).protein loaded onto the gel. The higher molecular band revealed in
In contrast to the difference in Ifi202 genotype andthe NZW sample has been shown not to be related to p202. The
expression between NZB and B6 strains, the above dataNZB sample shows several bands, including the same p202 as in
B6.Nba2 mice and possibly a phosphorylated form and a variant suggest that the Ifi202 promoter and expression were
form of p202 that migrates slower that the mouse p202 seen in similar in BALB/c and NZB strains. If polymorphism at
B6.Nba2 and various cell lines (Choubey and Lengyel, 1993), and a Ifi202 underlies lupus susceptibility conferred by Nba2,
higher molecular weight artifactual band similar to the one in the
the contribution of this region from NZB should be differ-NZW sample. The results shown are representative of four samples
ent in crosses involving B6 versus BALB/c backgrounds.from each strain analyzed concomitantly in two separate experi-
Therefore, we compared the strength of linkage of Nba2ments.
with lupus in two similarly designed backcrosses involv-
ing B6 or BALB/c mice congenic for H2z from NZW
(designated B6.H2z or BALB.H2z, respectively) (Rozzoimmunity are manifest, showed full expression of Ifi202
et al., 1996). Similar to previous reports, analysis showedsimilar to older NZB mice and many fold higher than B6
strong linkage of Nba2 with nephritis and various IgGmice (data not shown).
autoantibodies in (B6.H2z  NZB)F1  NZB backcrossWe also analyzed expression of the Ifi202-encoded
mice (Figure 6B). In contrast, linkage of Nba2 with ne-protein, p202, by immunoblotting with a previously de-
phritis and IgG antinuclear antibody production inscribed anti-p202 polyclonal antiserum (Choubey and
(BALB.H2z  NZB)  NZB backcross mice was muchLengyel, 1993). The amount of protein in spleen cell
weaker and, in most cases, not significant. Polymor-lysates among the different strains correlated with
phism at Ifi202 therefore correlates with the contributionmRNA expression levels (Figure 5B). Thus, no protein
of Nba2 to lupus in these two crosses.was detectable in B6 cells, whereas a strong band was
apparent in B6.Nba2 cells. NZW spleen cells also had
no detectable p202 protein. The higher molecular weight Increased Ifi202 Expression in B Cells and Studies of
Cellular Accumulation and Apoptosisband detected in the NZW sample has been shown to
be unrelated to p202 (D.C. and H. Xin, unpublished data). We also quantitated Ifi202 levels in different NZB splenic
cell populations, including CD4	 T cells, B220	 B cells,Interestingly, NZB spleen cells showed high protein ex-
pression, which was supplemented by the presence of and non-T/non-B cells. The increased expression of
Ifi202 in total NZB spleen was due mostly to increasedadditional bands, including possibly a phosphorylated
Susceptibility Genes in Murine Lupus
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Figure 6. Ifi202 Promoter Region Polymor-
phisms in Different Strains and Correlation
with the Contribution of Nba2 to Lupus
(A) Polymorphisms in the Ifi202 promoter re-
gion in NZB compared with B6 DNA. Posi-
tions are numbered relative to the most up-
stream transcription start site in B6 DNA
(Choubey et al., 1989). Another polymor-
phism, a 2 bp (AG) deletion at position 763
in NZB, is not shown. The positions of a se-
quence related to the interferon stimulated
response element (ISRE-like) and Friedman
Stark sequence are indicated. The nucleotide
at position 95 for the different strains tested
is also indicated. Also shown are the results
of a SNP genotyping assay for the polymor-
phism at position 95. The data are presented
as Delta CT, the difference in cycle number
to achieve detectable amplification with the
forward allele-specific primer with a 3 T com-
pared with the forward allele-specific primer
with a 3 C.
(B) Contribution of Nba2 to lupus in back-
crosses involving B6 versus BALB back-
grounds. Linkage analyses in the two
backcrosses are shown for the marker Crp
(1, 94), the closest marker to Ifi202 used
in both backcrosses. Linkage with nephritis
(categorized as positive or negative) was
quantified by 
2 analysis using a standard 2
2 contingency matrix and then converted to
an equivalent lod score. Analysis of this locus
as a quantitative trait locus (QTL) in linkage
with autoantibody levels was calculated us-
ing the program MAPMAKER/QTL (Lincoln et
al., 1992).
expression in B cells and non-B/non-T cells (Figure 7A). B6.Nba2 mice at 26 weeks of age was associated with
an expansion of particular B cell subsets, including aThe level of Ifi202 expression in NZB T cells could be
attributed to low-level (5%) non-T cell contamination nearly 3-fold increase in activated (CD69	) B cells and
a 2-fold increase in B cells that express Fas (CD95	).in the sorted CD4	 T cell population. Quantitative PCR
analyses of 2-microglobulin expression in the different Previous studies demonstrated that NZB B cells have
a defect in apoptosis induced by crosslinking surfacecell samples was nearly identical.
Consistent with changes in expression of a gene that B cell receptor (BCR) with anti-IgM Abs (Kozono et al.,
1996). B6 and B6.Nba2 B cells were compared in aaffects proliferation and apoptosis (Choubey, 2000;
Wang et al., 2000; D’Souza et al., 2001), congenic similar assay to see if the increased expression of Ifi202
was associated with any difference in apoptosis induc-B6.Nba2 mice were noted to have splenomegaly even
at an age prior to the development of lupus traits (Figure tion. Spleen cells were obtained from 10-week-old mice,
prior to the development of lupus-like disease, and anti-7B). For example, at 10 weeks of age, B6.Nba2 mice
showed a 2-fold increase in the number of spleen cells IgM-induced apoptosis was quantitated by staining with
Annexin V and quantitation of hypodiploid DNA (Figure(p  0.01) compared with B6 mice. This difference per-
sisted until later in life but did not increase further after 7C). In each of four experiments, the percentage of apo-
ptotic cells induced by anti-IgM was decreased in thethe development of elevated autoantibody levels. The
increased spleen cell number in congenic mice at 10 wells with B6.Nba2 cells compared with B6 cells (mean
difference in percent specific apoptosis  7.0  2.1,weeks of age was associated with a slight increase in
the proportion of B (CD19	) cells and a decrease in the range 3.3–11.6; p  0.05 by two-tailed t test for paired
samples).percentage of T (CD3	) cells. Both lymphocyte subsets,
however, were increased in absolute numbers com-
pared with B6 mice at 10 weeks of age (p  0.01). The Discussion
difference in percentage of B cells was more pro-
nounced at 26 weeks of age as was the relative decrease The present work focused on the gene underlying one
murine lupus-susceptibility locus, Nba2, which was pre-in percentage of T cells such that only B cells showed
a significant increase in cell numbers. The age-related viously shown to be a major genetic contribution from
the NZB strain to autoantibody production and diseasedrop in percentage of B cells in B6 mice was prevented
in B6.Nba2 mice. The increased proportion of B cells in in (NZB  NZW)F1 mice (Drake et al., 1995; Vyse and
Immunity
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of gp70-anti-gp70 immune complexes) in both congenic
and (B6.Nba2  NZW)F1 mice. This low production of
one specific type of autoantibody may relate to the miss-
ing contribution of H2d (from NZB) to the anti-gp70 re-
sponse (Vyse et al., 1999) as well as the need for other
NZB loci that control production of gp70 antigens
(Tucker et al., 2000).
Expression profiling of congenic and background B6
strains uncovered major differences in expression of
only two genes, and both mapped to the same cluster
within the Nba2 region. This remarkable result, consider-
ing the number of probe sets on the oligonucleotide
microarray, is likely related to the close genetic relation-
ship of the strains being examined and the fact that mice
were studied before full expression of their autoimmune
phenotype. Thus, changes secondary to the autoimmune
process were avoided. Congenic strains with other lu-
pus-susceptibility loci or even other disease-suscepti-
bility loci should be amenable to a similar approach if
differential expression of a particular gene is responsi-
ble. Either high Ifi202 or low Ifi203 could functionally
underlie the Nba2 contribution. We focused on Ifi202
because Ifi203 expression in B6 mice has recently been
suggested to be reciprocal to expression of Ifi202 (Gri-
baudo et al., 1999). The marked increase in expression
in B6.Nba2 versus B6 mice was confirmed for both Ifi202
mRNA and p202 protein levels. Importantly, we also
found polymorphisms in the Ifi202 promoter region that
could explain the differences in expression between
NZB (B6.Nba2) and B6 strains as well as between NZB
Figure 7. Analysis of Ifi202 Expression in Spleen Cell Subsets and and NZW. Thus, the genetic basis for the difference in
Studies of Alterations in Spleen Cell Subsets and Apoptosis expression would be at the level of Ifi202 expression.
(A) Quantitative PCR analysis of mRNA expression relative to B6 We also used the strain distribution of Ifi202 promoter
total spleen cells for NZB spleen cells, CD4	 T cell, B220	 B cell, region polymorphisms to help assess the possible role
and non-T/non-B subsets. All samples were corrected by the level
of this gene in the Nba2 contribution to lupus. In theof B2m (encoding 2-microglobulin) expression, which was nearly
comparison of two similarly designed backcrosses, weidentical in the different cell samples analyzed.
noted a strong contribution to lupus traits from Nba2 in(B) Spleen cell numbers and lymphocyte subsets in B6 and B6.Nba2
mice. Data are shown for matched samples from mice at ages 10 a backcross in which either NZB or B6 alleles were
weeks (before autoantibody production) and 26 weeks (after auto- inherited. In contrast, inheritance of this NZB chromo-
antibody production). There were four mice in each group. Signifi- somal region made little difference in a backcross in
cant differences by Student’s t test between B6.Nba2 and B6 values: which either NZB or BALB alleles were inherited. It is
*p  0.05; **p  0.01.
important to emphasize that this analysis focused on(C) Apoptosis of B cells from B6 and B6.Nba2 mice after induction
one distal chromosome 1 region and that in geneticby anti-IgM antibodies. Data are shown as mean percent specific
crosses with autoimmune mice, other regions of the B6apoptosis for B cell samples from paired B6 (open bars) and B6.Nba2
(closed bars) mice. The difference between the two strains was versus BALB genomes (including MHC) will differentially
significant at p  0.05 as determined by a two-tailed paired t test. influence the expression of autoimmune traits (Rozzo et
al., 1996). In this regard, deficiency of the low-affinity
receptor for IgG-Type IIB (FcRIIB) causes lupus when
Kotzin, 1998; Rozzo et al., 1996, 2000; Vyse et al., 1997, bred to B6 mice but not when bred to BALB mice (Bol-
1998; Kono et al., 1994). B6 mice congenic for this NZB land and Ravetch, 2000). It is possible that genes else-
region were generated, and these mice demonstrated where in BALB, compared with B6, also do not allow
elevated serum levels of IgG antinuclear autoantibodies. for the contribution of Nba2 to lupus. Although still other
The absence of lupus nephritis in the congenic mice is mechanisms may explain the differences in the two
consistent with the need for multiple susceptibility crosses, the data are consistent with a role for Ifi202 in
genes for full expression of lupus (Vyse and Kotzin, 1998; lupus susceptibility. The weak trend for linkage with
Theofilopoulos and Kono, 1999; Wakeland et al., 1999). some traits in the BALB backcross could also suggest
Indeed, when B6.Nba2 mice were bred to NZW mice, that there are other NZB genes on distal chromosome
autoantibody production and the incidence of nephritis 1 that contribute to lupus-like disease. Studies have
approached that seen in (NZB  NZW)F1 mice. These suggested that genomic regions with strong contribu-
results support the importance of Nba2, relative to other tions to disease may harbor several linked contributing
NZB lupus-susceptibility loci, as suggested in past link- genes, as has been shown for the Sle1 contribution from
age studies. One difference in our congenic studies NZW mice in this region (Morel et al., 2001).
compared with past analyses is the low levels of auto- NZW mice also harbor a lupus-susceptibility locus
(named Sle1) on distal chromosome 1, and B6 miceantibodies to endogenous retroviral gp70 (in the form
Susceptibility Genes in Murine Lupus
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congenic for this locus produce IgG antinuclear antibod- disease (Kozono et al., 1996). Inhibition of B cell apopto-
ies and contribute to lupus-like disease (Mohan et al., sis is also consistent with the expansion of spleen cells
1998; Morel et al., 2000, 2001). It has been debated as in congenic mice and the relative increase in proportion
to whether the distal chromosome 1 contribution from and numbers of B cells, activated B cells, and B cells
NZB (Nba2 or Lbw7) and NZW (Sle1) reflect the same expressing Fas in B6.Nba2 mice, especially with age.
lupus-susceptibility gene (Vyse and Kotzin, 1998; Wake- Although congenic mice demonstrated increased num-
land et al., 1999). The data in our present work suggest bers of T and B lymphocyte subsets, previous studies
that the most important contribution from these two have shown that selective defects in B cell apoptosis
New Zealand strains is not the same because the levels or B cell activation and proliferation, on the right genetic
of Ifi202 expression in B6 and NZW mice were similar background, will lead to T and B cell expansions and
and much lower than NZB. Furthermore, both NZW and lupus (Sobel et al., 1991; Bolland and Ravetch, 2000).
B6 had reciprocally high levels of Ifi203 expression. Con- Support for Ifi202 as a contributing gene in systemic
sistent with this conclusion, we noted that the types of lupus also derives from its regulation by interferon. The
antibodies produced by age- and sex-matched B6 mice enhancing role of interferons in both murine lupus and
congenic for Nba2 versus Sle1 were considerably differ- SLE has been well documented (Lawson et al., 2000),
ent (S.J.R. and B.L.K., unpublished data). For example, and the Ifi200 genes could be a mediator of this effect
although both strains made antibodies to chromatin, on disease expression. At this time, it is not known
levels were 10-fold higher in the Nba2 congenics, and whether the high constitutive expression of Ifi202 in NZB
high levels of autoantibodies to dsDNA and free histones mice is interferon dependent.
were limited to the Nba2 congenics. Although genetic mapping studies in murine models
The Ifi200 gene cluster on murine distal chromosome of lupus have been guides to syntenic regions in humans
1 encodes one family of structurally related interferon- for susceptibility loci, the results from genetic analyses
inducible proteins, characterized by at least one repeat of animal models may be most useful once an actual
of a partially conserved 200 amino acid segment (Choubey susceptibility gene is identified. Not only could the same
et al., 1989; Landolfo et al., 1998; Johnstone and Trapani, gene be examined for linkage and/or association with
1999; Wang et al., 1999). Expression of these genes is human SLE, but also other genes encoding molecules
increased by type 1 and type 2 interferons to various in the same or related biological pathways could be
degrees. A homologous segment on human chromo- tested in a directed fashion. The present studies provide
some 1 includes three structurally related genes (Lan- evidence for a novel type of candidate gene and novel
dolfo et al., 1998; Johnstone and Trapani, 1999). Inter- pathways to explore in lupus susceptibility.
estingly, this chromosomal segment colocalizes with
lupus-susceptibility loci mapped in genome scans of
Experimental ProceduresSLE families (Harley et al., 1998; Wakeland et al., 1999).
Ifi202 generates a 52 kDa protein (p202), and, after in- Mice and Evaluation for Lupus Traits
duction, this protein accumulates in the cytoplasm and NZB/BINJ, NZW/LacJ, C57BL/6 (B6), and BALB/c (BALB) mice were
then translocates into the nucleus (Choubey and Leng- obtained from the Jackson Laboratories and were maintained in the
animal care facility at the University of Colorado Health Sciencesyel, 1993; Choubey, 2000; Landolfo et al., 1998). Also
Center (Denver, CO). B6.NZB-Nba2 (designated B6.Nba2) mice wereconsistent with its role in transcriptional regulation, this
generated by breeding (NZB  B6)F1 mice and then backcrossingprotein binds to several relevant transcription factors
an NZB interval on distal chromosome 1 to the B6 strain. Inherited(Choubey and Gutterman, 1997; Choubey and Lengyel,
NZB regions were mapped with microsatellite markers polymorphic
1995; Choubey et al., 1996; Datta et al., 1996; Landolfo between NZB and B6 as previously described (shown in Figure 1)
et al., 1998; Min et al., 1996; Wang et al., 2000). Increased (Rozzo et al., 1996, 2000; Vyse et al., 1997, 1998). The positions of
expression inhibits cell proliferation, which may partially markers and various candidate genes with respect to the centro-
mere are given in accordance with the Mouse Chromosome Com-mediate the antiproliferative effect of the interferons
mittee Reports (obtainable from the Mouse Genome Database at(Gutterman and Choubey, 1999; Landolfo et al., 1998;
http://www.informatics.jax.org). After ten generations of backcross-Choubey, 2000). Studies have also suggested that in-
ing, siblings were intercrossed to generate B6.Nba2 congenic micecreased expression of p202 inhibits apoptosis (Wang et homozygous for the NZB chromosome 1 interval (Figure 1). Genomic
al., 2000; D’Souza et al., 2001) and that the decreased DNA from other strains was obtained from the Jackson Laboratories.
expression of p202 increases susceptibility to apoptosis Sera from 7-month-old B6.NZMSle1 mice (Mohan et al., 1998) were
under certain physiological conditions (Koul et al., 1998). kindly provided by Laurence Morel (Gainesville, FL).
Female study mice were followed for the development of lupusInhibition of B cell apoptosis may be a mechanism by
nephritis by measuring proteinuria at monthly intervals as previouslywhich increased expression of p202 enhances lupus
described (Drake et al., 1995; Rozzo et al., 1996, 2000; Vyse et al.,susceptibility. Apoptosis is critically involved in the
1997, 1998). Mice with 2	 or greater proteinuria, on at least two
maintenance of B cell tolerance (Goodnow et al., 1995), consecutive occasions before 12 months of age, were designated
and studies have shown that inhibition of B cell apopto- as positive for high grade proteinuria and severe renal disease. The
sis through mutation of the gene encoding Fas (lpr) con- validity of using proteinuria to document severe renal disease and
tributes to the development of murine lupus (Sobel et predict mortality from renal failure in New Zealand hybrid mice has
been previously demonstrated (Drake et al., 1995; Rozzo et al., 1996,al., 1991). In the present studies, we noted that high
2000; Vyse et al., 1997, 1998, 1999).levels of Ifi202 were especially prominent in B6.Nba2
Autoantibody levels to chromatin, dsDNA, and total histones wereand NZB B cells. B cells from B6.Nba2 mice also demon-
determined by enzyme-linked immunosorbent assays as described
strated a defect in apoptosis induced by crosslinking (Vyse et al., 1997). Autoantibodies to gp70 were quantitated as se-
BCR with anti-IgM antibodies. This defect was pre- rum levels of gp70-anti-gp70 immune complexes (gp70 IC) (Vyse et
viously observed in NZB mice and postulated to be a al., 1997) because the relative excess of gp70 in sera makes free
anti-gp70 antibodies difficult to detect.trait that contributed to the development of lupus-like
Immunity
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Spleen Cell Subset Analysis and Separation deoxycholate, 0.1% sodium dodecyl sulfate, 250 mM NaCl) sup-
plemented with protease inhibitors (leupeptin, 50 g per ml; Pep-For studies analyzing the expression of Ifi202 in different spleen cell
subsets, splenic mononuclear cells from NZB mice were stained statin A, 50 g per ml; phenylmethylsulfonyl fluoride, 1 mM), and
incubated at 4C for 30 min. Lysates were sonicated briefly beforewith fluorochrome-conjugated monoclonal antibodies to B220 (Phar-
mingen, San Diego, CA), CD4, and CD3 (ATCC) and separated on centrifugation at 14,000 g in a microfuge for 10 min. Supernatants
were collected, and equal amounts of proteins were processed fora MoFlo cell sorter (Cytomation, Fort Collins, CO). The contamination
level of nonstaining cells in the sorted CD4	 T cells and B220	 B immunoblotting using antiserum to p202 as described previously
(Choubey and Lengyel, 1993), except that chemiluminescence (ECL;cells was less than 5%. For studies analyzing lymphocyte subsets
in B6.Nba2 and B6 mice, spleen cells were stained with mAbs to Amersham) was used to detect secondary antibodies. Four samples
from each strain were analyzed.CD19, CD3, CD69, or CD95 (Pharmingen) in various two-color com-
binations and analyzed on a FACScan flow cytometer (Becton Dick-
inson, Franklin Lakes, NJ). Anti-IgM Induced B Cell Apoptosis
B cell apoptosis induced following ligation of surface IgM was per-
Microarray Assays formed similarly to methods previously described (Kozono et al.,
Oligonucleotide microarrays (Mu11K GeneChip probe arrays; Affy- 1996). Single-cell suspensions from individual mouse spleens were
metrix) were hybridized with labeled cRNA derived from spleen cells depleted of erythrocytes by hypotonic lysis, and T cells were de-
and kidney from individual mice using previously described methods pleted to less than 1% using anti-Thy 1.2-coated magnetic beads
(Karp et al., 2000). Differential expression, as analyzed by GeneChip (Dynabeads; Dynal Biotech). Cells (1  106 per ml) were cultured
3.1 software (Affymetrix), was assessed by pairwise comparisons with and without 0.5 g/ml goat anti-mouse IgM (Southern Bio-
of samples from individual 4-month-old (preautoimmune) B6.Nba2 technology, Birmingham, AL) for 18 hr prior to harvesting and as-
mice and B6 mice. Criteria for differential expression required in- sessment of apoptosis. Each culture condition was performed in
creases (or decreases) in 12 of the 16 possible pairwise compari- quintuplicate. Cultured cells were analyzed for apoptosis by two
sons. Expression levels (Average Difference Value; GeneChip 3.1 techniques: staining with Annexin V and propidium iodide (PI) (Vy-
software) are presented for the probe sets derived from the Ifi202, brant Apoptosis Assay kit #3; Molecular Probes, Eugene, OR) and
Ifi203, and Ifi204 full-length cDNAs. quantitation of hypodiploid DNA. Annexin V and PI staining were
conducted according to the manufacturer’s directions, and the sam-
ples were analyzed immediately afterward using a FACScan flowKinetic Real-Time PCR for Quantitation of Relative Levels
cytometer (Becton Dickinson). For hypodiploid DNA analysis, cellsof mRNA
were resuspended in 80% ethanol, incubated at 20C overnight,After treatment with Dnase 1 (GIBCO, Carlsbad, CA), total RNA (100
treated with RNase A (Sigma), incubated in 500 ng/ml PI, and ana-ng) was subjected to RT-PCR using 2 U rTh DNA polymerase (PE
lyzed by flow cytometry after gating on the sub-G0 peak. PercentApplied Biosystems, Foster City, CA) in a 100 l reaction mix con-
specific apoptosis was calculated as ([percent induced apoptosis taining 5X EZ buffer, Mn(Oac) (3 mM), ethidium bromide (1 g/l),
percent spontaneous apoptosis] / [100 percent spontaneous apo-dNTPs (200 M), forward primer (200 nM), and reverse primer (200
ptosis])  100 (Kozono et al., 1996).nM). Generation of cDNA for 30 min at 60C was followed by kinetic
PCR (95C, 20 s; 58C, 20 s), performed with a GeneAmp 5700
Sequence Detection system (PE Applied Biosystems) and software Acknowledgments
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